. Author manuscript; available in PMC: 2011 Oct 1.

Published in final edited form as: Mol Genet Metab. 2010 Jul 23;101(2-3):115–122. doi: 10.1016/j.ymgme.2010.06.020

Table 4.

Glycosaminoglycan levels in spinal meninges by region.

	Untreated (n=4)	IT + IV Adult (n=3)	IT + IV Early (n=4)	IV Adult (n=4)	0.58 mg/kg IV Early (n=4)	1.57 mg/kg IV Early (n=3)	Normal (n=4)
Cervical	25.4 ± 6.39	13.1 ± 2.89^*	5.80 ± 2.49^*	40.3 ± 9.01	18.2 ± 4.40	12.6 ± 1.45^*	4.45 ± 0.438
Thoracic	41.8 ± 8.85	18.3 ± 6.13^*	5.47 ± 0.402^*	59.6 ± 21.4	19.6 ± 5.75^*	10.4 ± 2.22^*	4.32 ± 1.20
Lumbar	47.4 ± 7.94	24.0 ± 4.89^*	6.27 ± 2.29^*	33.0 ± 3.07^*	23.4 ± 9.03^*	12.2 ± 8.68^*	5.56 ± 2.21

p<0.05 versus untreated, by post-hoc Dunnett's test, one-sided